Literature DB >> 26770628

Percutaneous transhepatic embolization of gastroesophageal varices combined with partial splenic embolization for the treatment of variceal bleeding and hypersplenism.

Wei-Dong Gong1, Ke Xue2, Yuan-Kui Chu3, Qing Wang3, Wei Yang1, Hui Quan2, Peng Yang4, Zhi-Min Wang1, Zhi-Qun Wu1.   

Abstract

This study aims to evaluate the therapeutic results of percutaneous transhepatic embolization of gastroesophageal varices combined with partial splenic embolization in patients with liver cirrhosis, and to explore the role of this minimally invasive treatment as an alternative to surgery. 25 patients with liver cirrhosis were received percutaneous transhepatic embolization of gastroesophageal varices combined with partial splenic embolization. Another 25 patients with liver cirrhosis underwent Hassab's operation. They were followed up, and received endoscopy, B ultrasound, liver function and hematologic examination at 24 months after the therapy. In minimal invasive group, before treatment and after 24 month following up after treatment, improved varices, improved portal hypertension and improved hypersplenism were showed comparing with the surgery group, and that they were measured by endoscopic visualization, ultrasound and blood counts. the white blood cell and platelet count were 2.33±0.65 (10(9)/L) and 3.63±1.05 (10(10)/L), 7.98±3.0 (10(9)/L) and 16.3±9.10 (10(10)/L) (P<0.05); the diameter of the portal vein were 1.47±0.25 cm, 1.31±0.23 cm (P<0.05). Esophageal varices passed from grade III to lower grade II in 11 patients, and from grade II to lower grade I in 6 patients at 24 month following up. In surgical group, the white blood cell and platelet count were 2.2±0.60 (10(9)/L), 4.1±1.25 (10(10)/L) before treatment; 9.3±2.56 (10(9)/L), 32.1±12.47 (10(10)/L) after the treatment at 24 month following up (P<0.05). The diameter of the portal vein were 1.43±0.22 cm before the treatment and 1.28±0.18 cm after the treatment (P<0.05). Esophageal varices passed from grade III to lower grade II in 13 patients, and from grade II to lower grade I in 7 patients. The combination of PGEV and PSE can be considered as an option for the treatment of variceal bleeding with hypersplenism.

Entities:  

Keywords:  Partial splenic embolization; hypersplenism; percutaneous transhepatic embolization of gastroesophageal varices; variceal bleeding

Year:  2015        PMID: 26770628      PMCID: PMC4694528     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  27 in total

1.  Endoscopic injection sclerotherapy in the management of 2105 patients with esophageal varices.

Authors:  Morimasa Tomikawa; Makoto Hashizume; Keishi Okita; Seigo Kitano; Masayuki Ohta; Hidefumi Higashi; Tomohiko Akahoshi
Journal:  Surgery       Date:  2002-01       Impact factor: 3.982

2.  [Pericardial devascularization with splenectomy for the treatment of portal hypertension].

Authors:  Z Yang; F Qiu
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2000-09

Review 3.  Transjugular intrahepatic portosystemic shunt: present status, comparison with endoscopic therapy and shunt surgery, and future prospectives.

Authors:  J Rösch; F S Keller
Journal:  World J Surg       Date:  2001-04-11       Impact factor: 3.352

4.  A modified percutaneous transhepatic variceal embolization with 2-octyl cyanoacrylate versus endoscopic ligation in esophageal variceal bleeding management: randomized controlled trial.

Authors:  Chun Qing Zhang; Fu Li Liu; Bo Liang; Zi Qin Sun; Hong Wei Xu; Lin Xu; Kai Feng; Zun Chang Liu
Journal:  Dig Dis Sci       Date:  2007-11-21       Impact factor: 3.199

5.  Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization.

Authors:  Kenji Ohmoto; Naoko Yoshioka; Yasuyuki Tomiyama; Norikuni Shibata; Michihiko Takesue; Koji Yoshida; Makoto Kuboki; Shinichiro Yamamoto
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

Review 6.  The management of portal hypertension: rational basis, available treatments and future options.

Authors:  Jaime Bosch; Annalisa Berzigotti; Juan Carlos Garcia-Pagan; Juan G Abraldes
Journal:  J Hepatol       Date:  2008-02-12       Impact factor: 25.083

Review 7.  New methods for the management of esophageal varices.

Authors:  Hiroshi Yoshida; Yasuhiro Mamada; Nobuhiko Taniai; Takashi Tajiri
Journal:  World J Gastroenterol       Date:  2007-03-21       Impact factor: 5.742

Review 8.  Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding.

Authors:  G D'Amico; A Luca
Journal:  Baillieres Clin Gastroenterol       Date:  1997-06

9.  Percutaneous transhepatic embolization of gastroesophageal varices: results in 400 patients.

Authors:  C L'Herminé; P Chastanet; O Delemazure; P L Bonnière; J P Durieu; J C Paris
Journal:  AJR Am J Roentgenol       Date:  1989-04       Impact factor: 3.959

10.  Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators.

Authors:  Gennaro D'Amico; Roberto De Franchis
Journal:  Hepatology       Date:  2003-09       Impact factor: 17.425

View more
  2 in total

Review 1.  Progress in Endoscopic and Interventional Treatment of Esophagogastric Variceal Bleeding.

Authors:  Bin Liu; Gang Li
Journal:  Dis Markers       Date:  2022-05-06       Impact factor: 3.464

2.  Treatment of symptomatic splenomegaly with low doses of radiotherapy: Retrospective analysis and review of the literature.

Authors:  Carolina de la Pinta; Eva Fernández Lizarbe; Ángel Montero Luis; José Antonio Domínguez Rullán; Sonsoles Sancho García
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2017-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.